BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 19, 2021
View Archived Issues
Phase II data reported for cabozantinib in type I neurofibromatosis with PNs
Read More
BET inhibitors synergize with BCL-2 or HDAC inhibitors in Waldenstrom macroglobulinemia
Read More
Grifols to begin clinical evaluation of new COVID-19 treatment
Read More
Biohaven presents focused analysis data from phase II/III study of troriluzole in AD
Read More
First patient dosed in phase II study of alisporivir in early-stage COVID-19
Read More
Eli Lilly initiates phase II study of LY-3462817 in rheumatoid arthritis
Read More
Enrollment opens in phase II study of vactosertib plus pembrolizumab in NSCLC
Read More
Murine model of SARS-CoV-2 infection developed via mRNA transfection of hACE2
Read More
Sobetirome and its prodrug show efficacy in models of EAE
Read More
LCP2 is a therapeutic target in lethal sepsis
Read More
Shanghai Institute of Materia Medica dicloses new hepatitis B virus inhibitors
Read More
New CDK9/cyclin T1 inhibitors discovered at Medshine Discovery
Read More
Preclinical data show SENS-401 reduces loss of residual hearing after cochlear implantation
Read More
Hangzhou Hertz Pharmaceutical patents casein kinase 1 isoform epsilon inhibitors
Read More
DMC recommends start of part 2 of COVA study of Sarconeos in COVID-19
Read More
Guangdong Newopp Biopharmaceuticals identifies mutant KRAS inhibitors
Read More
New JAK inhibitors synthesized at Guangzhou Innocare Pharma Tech
Read More
Phase I trial of LY-CovMab in China completes enrollment
Read More
Novel GPC3/CD47 bispecific antibody shows strong antitumor activity in HCC xenografts
Read More
HELP is on its way for herpetic stromal keratitis
Read More
Transgene gains clearance in France for phase I/IIa study of BT-001 for solid tumors
Read More
CRY1 unveiled as a hormone-induced tumorigenic factor in prostate cancer
Read More